The goal of the proposed research is to study the basis of T cell-mediated immune recognition of xenogeneic cellular grafts, using islets of Langerhans as a relevant model system. Data obtained during the funding period strongly suggests that the prevalent mode of xenogenic islet recognition is through the indirect pathway of antigen recognition by recipient's CD4+ T lymphocytes.
In Specific Aim I a, several immunodeficient mice will be used to determine the mechanisms of CD4+ T lymphocyte-dependent xenoreactivity towards rat islets. The notion that islet xenografts survive in nude and SCID recipients strongly suggests that, it least in murine recipients, rejection of such grafts is dependent on T cells. Furthermore, evidence was obtained during the first funding period that such cellular response is CD4+ T cell-dependent in vivo. The first goal of this proposal is to analyze the role of molecules involved in target cell destruction in xenograft rejection via direct lysis (perforin), via induction of apoptosis (Fas L) and by mediation of inflammation (IFN-g). Perforin deficient mice (PKO), Fas L deficient mice (gld/gld) and IFN-g deficient mice will be used as donors of CD4+ T cells, which will be transferred into RAG1-/- recipients. RAG 1-/- (T and B cell deficient, not as leaky as SCID mice) recipients will be previously transplanted with rat islets. The hypothesis tested by this series of experiments is that CD4 T cell-mediated rejection of xenogeneic islets requires triggering of inflammation, but it does not require the presence of intact cell-cytotoxicity mediating molecules. Therefore the expected results (supported by preliminary findings) are that PKO CD4 cells will induce rat islet rejection in times similar to those of WT CD4 cells, while IFN-g-deficient CD4 cells will be significantly less efficient in mediating graft rejection. While the pivotal role of CD4+ T cells in xenogeneic islet rejection has been established, it can not be formally ruled out that non T cell-mediated effector mechanisms might contribute (partially or entirely) to the observed phenomena.
Specific Aim I b is therefore set forth to explore this working hypothesis.
Specific Aim I c will test the hypothesis that CD4+ T cell-mediated rejection of xenogeneic grafts might not require T cell receptor-mediated interaction with the grafted target cells.
Specific Aim I d is focused on the analysis of rejection of discordant islet grafts in the pig to mouse model system.
In Specific Aim II, the P.I. proposes to investigate the mechanisms that mediate the induction of long term survival of xenogeneic islets grafted in mice treated with a short course of anti-LFA-1 antibodies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK045773-09
Application #
6342460
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Eggerman, Thomas L
Project Start
1993-01-01
Project End
2002-12-31
Budget Start
2001-01-01
Budget End
2001-12-31
Support Year
9
Fiscal Year
2001
Total Cost
$202,429
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Plenter, Robert J; Grazia, Todd J; Coulombe, Marilyne G et al. (2018) Anti-LFA-1 induces CD8 T-cell dependent allograft tolerance and augments suppressor phenotype CD8 cells. Cell Immunol 332:101-110
Plenter, Robert J; Grazia, Todd J; Nelson, David P et al. (2015) Ectopic expression of Fas Ligand on cardiomyocytes renders cardiac allografts resistant to CD4(+) T-cell mediated rejection. Cell Immunol 293:30-3
Plenter, Robert J; Grazia, Todd J; Doan, An N et al. (2012) CD4 T cells mediate cardiac xenograft rejection via host MHC Class II. J Heart Lung Transplant 31:1018-24
Rayat, Gina R; Gill, Ronald G (2005) Indefinite survival of neonatal porcine islet xenografts by simultaneous targeting of LFA-1 and CD154 or CD45RB. Diabetes 54:443-51
Johnson, Z; Beilke, J; Pietra, B et al. (2004) Distinct requirements for host CD80/CD86 costimulatory molecules in cardiac versus islet rejection. Transplant Proc 36:1171-2
Rayat, Gina R; Johnson, Zachary A; Beilke, Joshua N et al. (2003) The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection. Diabetes 52:1433-40
Rayat, Gina R; Gill, Ronald G (2003) Pancreatic islet xenotransplantation: barriers and prospects. Curr Diab Rep 3:336-43
Coulombe, M; Gill, R G (1996) T lymphocyte indifference to extrathymic islet allografts. J Immunol 156:1998-2003
Gill, R G; Wolf, L (1995) Immunobiology of cellular transplantation. Cell Transplant 4:361-70
Wolf, L A; Coulombe, M; Gill, R G (1995) Donor antigen-presenting cell-independent rejection of islet xenografts. Transplantation 60:1164-70

Showing the most recent 10 out of 13 publications